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Abstract – A novel reductive amino-cyclization method for the synthesis of 
azacycloalkanes is developed. Its versatility is proved by the total syntheses of 
(±)-aurantioclavine (1), an ergot alkaloid, and (±)-lophocerine (2), a cactus 
alkaloid, as examples of azepane and piperidine skeletons, respectively.
In our project for developing biologically active compounds,2 we needed a novel simple method for 
constructing azacycloalkanes under acidic conditions. Generally speaking, however, the formation of a 
C—N bond between nitrogen atom of amines and carbocation generated in situ by the action of an acid is 
impossible, because the basic nitrogen is protonated completely and eventually loses the nucleophilic 
ability. 
To overcome the problem we have conceived the following idea as shown in general formula in Scheme 
1. If the type A compound, having both nitro and unsaturated groups in a molecule, is subjected to an 
acidic reduction (in this case, E+ = H+), the nitrogen atoms of both the resulting intermediates, 
hydroxylamine (B) or oxime (C), would not be protonated completely due to the attached 
electron-attracting oxygen atom. So, in cases where a carbocation is generated in the neighborhood of the 
nitrogen atom, both carbon and nitrogen atoms can connect together resulting in the formation of a cyclic 
hydroxylamine or a cyclic nitrone (D). Simultaneous acidic reduction can provide the desired type E 
azacycloalkanes.  
On the basis of the above idea, we have succeeded in creating a novel reductive amino-cyclization 
method.3 We wish to report its application for the total syntheses of (±)-aurantioclavine4 (1), a member of 
ergot alkaloid and (±)-lophocerine (2), a cactus alkaloid, as examples of azepane and a piperidine forma-  
# Dedicated to the 75th birthday of Prof. Dr. Ekkelhard Winterfeldt. 
 tions, respectively (Scheme 2). Part of these works is reported as preliminary communications.3,6 
As for an example of pyrrolidine formation, we had already applied the method for the synthesis of 
6,6a,7,8,9,9a-hexahydro-2H-isoindolo[4,5,6-cd]indole3,6 (3), a synthetic intermediate for α-cyclopiazonic 
acid (4). We had demonstrated as well that the process, C → D in Scheme 1, actually worked.7 Thus, 
the compound (5) was successfully converted to a nitrone (6, in this case, E+ = Br+), an important 







































S1—S3: an appropriate substituent. E+: an electrophile.
 
 
An Efficient Total Synthesis of (±)-Aurantioclavine (1) 
According to our synthetic procedures,6,8 we first prepared (E)-2-methyl-4-[3-(2-nitroethyl)indol- 
4-yl]-3-buten-2-ol (9, Scheme 2), our common synthetic intermediate for the ergot alkaloids,2 in 46% 
overall yield from indole-3-carbaldehyde (8) in four steps.8 Since the compound (9) contains the type A 
structure, the desired allyl cation being a benzyl cation as well, can be generated on the side chain at the 
4-position of 9 by an acid treatment. The carbocation is so stable that it would survive during the time 
when the acidic reduction of the nitro group on the side chain at the 3-position of 9 proceeds, and it 
would eventually have a chance to form a bond to the hydroxylamine nitrogen.  
Scheme 2
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 In fact, however, treatment of 9 with such reagent systems as SnCl2/HCl/MeOH, TiCl3/MeOH, Fe/AcOH, 
and Zn/AcOH ended in failure under various examined reaction conditions. Finally, we tried 
amalgamated zinc (Zn (Hg)) and found it a reagent of choice. Thus, treatment of 9 with Zn (Hg) in 
refluxing methanolic HCl gave (±)-aurantioclavine (1) in 72% yield. Further treatment of 1 with Ac2O 
and pyridine afforded (±)-N-acetylaurantioclavine (10) in 93% yield. Spectral data of 1 were identical 
with those of aurantioclavine, reported in the literature.4 
Thus, we accomplished the first total synthesis of (±)-aurantioclavine (1) in the simplest five steps with a 
33% overall yield from 8 without using any protective groups. Hegedus’ group9 achieved the total 
syntheses of (±)-1 afterwards, too.10 
   
Total Synthesis of (±)-Lophocerine (2) 
In order to examine whether our amino-cyclization method works for the piperidine formation, we 
selected (±)-lophocerine (2)5 as a target molecule, which is known to exist as a racemate.5  
For the synthesis of intermediates having 1-substituted isoquinoline skeletons (12a,b, Scheme 3), we 
chose 4-[4,5-dimethoxy- (11a) and 4-[5-benzyloxy-4-methoxy-2-(2-nitroethyl)phenyl]-2-meth- 




















































Employing the reduction with NaBH4 in MeOH, compounds (11a,b11) were easily prepared in 74 and 
81% yields, respectively, from 13a and 13b.11 They were prepared according to our procedures11 from 
6-bromoveratraldehyde (14a) and 6-bromo-4-benzyloxy-3-methoxybenzaldehyde (14b) in two steps 
through 15a and 15b.   
The reductive amino-cyclization method, using zinc instead of Zn (Hg), was successfully applied for 11a 
and 11b. Thus, treatment of 11a and 11b with zinc in refluxing methanolic HCl provided 6,7-dimethoxy- 
 (12a) and 7-benzyloxy1-6-methoxy-1-(2-methyl-1-propen-1-yl)-1,2,3,4-tetrahydroisoquinoline (12b) in 
67 and 77% yields, respectively. 
Further treatment of 12b with ClCO2Me and Et3N afforded 7-benzyloxy-6-methoxy-2-methoxy- 
carbonyl-1-(2-methyl-1-propen-1-yl)-1,2,3,4-tetrahydroisoquinoline (16) in 99% yield. Subsequent 
reduction of 16 with LiAlH4 in dry THF gave 7-benzyloxy-1-(2-methyl-1-propen-1-yl)-6-meth- 
oxy-2-methyl-1,2,3,4-tetrahydroisoquinoline (17) in 86% yield together with an 11% yield of the 
debenzylated compound 18. Catalytic hydrogenation of the double bond and debenzylation of 17 over 
10% Pd/C in MeOH produced (±)-lophocerine (2) in 39% yield. Our synthesized 2 and its picrate were 
identical with the samples prepared according to the procedure described in the literature.5  
In conclusion, we have established a novel reductive amino-cyclization method for the synthesis of 
azacycloalkanes based on our idea shown in Scheme 1. Its versatility was proved by the total syntheses 
of (±)-aurantioclavine (1) and (±)-lophocerine (2) as examples of the azepane and piperidine skeletons, 
respectively. 
EXPERIMENTAL 
Melting points were determined on a Yanagimoto micro melting point apparatus and are uncorrected. IR 
spectra were determined with a Shimadzu IR-420 spectrophotometer, and 1H-NMR spectra with a JEOL 
JNM-PMX 60 or a JEOL FX-100 spectrometer, with tetramethylsilane as an internal standard. MS were 
recorded on a Hitachi M-80 spectrometer. Preparative thin-layer chromatography (p-TLC) was 
performed on Merck Kiesel-gel GF245 (Type 60) (SiO2). Column chromatography was performed on 
silica gel (SiO2, 100—200 mesh, from Kanto Chemical Co., Inc.) throughout the present study. 
(±)-Aurantioclavine (1) from (E)-2-Methyl-4-[3-(2-nitroethyl)indol-4-yl]-3-buten-2-ol (9) — A 
solution of 9 (113.2 mg, 0.41 mmol) in MeOH (24 mL) and 3% HCl (8 mL) was added to Zn (Hg), 
prepared from Zn powder (1.386 g, 21.2 mmol) and HgCl2 (229.0 mg, 0.84 mmol) in 3% HCl (8 mL), 
and the mixture was refluxed for 3.5 h with stirring. Unreacted Zn (Hg) was filtered off and the filtrate 
was evaporated under reduced pressure. The residue was made basic by adding 8% NaOH and the whole 
was extracted with CH2Cl2–MeOH (95:5, v/v). The organic layer was washed with brine, dried over 
Na2SO4, and evaporated under reduced pressure to leave an oil, which was subjected to p-TLC on SiO2 
with CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) as a developing solvent. Extraction of the band having 
an Rf value of 0.29—0.58 with CHCl3–MeOH-28% aq. NH3 (46:5:0.5, v/v) gave 1 (66.9 mg, 72%). 1: 
mp 194—196°C (colorless leaves, recrystallized from CH2Cl2–hexane). IR (KBr): 3290, 2915 cm-1. 
1H-NMR (CDCl3) δ: 1.71 (1H, br s, disappeared on addition of D2O), 1.84 (6H, s), 2.83—3.24 (3H, m), 
3.33—3.71 (1H, m), 4.86 (1H, d, J=9.0 Hz), 5.44 (1H, br d, J=9.0 Hz), 6.80 (1H, br d, J=6.8 Hz), 
 6.89—7.27 (2H, m), 6.94 (1H, br s), 8.17 (1H, br s, disappeared on addition of D2O). MS m/z: 226 (M+). 
Anal. Calcd for C15H18N2: C, 79.60; H, 8.02; N, 12.38. Found: C, 79.52; H, 8.10; N, 12.53. 
(±)-N-Acetylaurantioclavine (10) from 1 — Ac2O (1 mL) was added to a solution of 1 (53.1 mg, 0.24 
mmol) in pyridine (2 mL) and the mixture was stirred at rt for 13 h. After evaporation of the solvent, 
saturated aqueous NaHCO3 was added and the whole was extracted with CH2Cl2–MeOH (95:5, v/v). The 
organic layer was washed with brine, dried over Na2SO4, and evaporated under reduced pressure to leave 
a solid, which was recrystallized from MeOH to give 10 (58.5 mg, 93%) as colorless needles. 10: mp 
235—236°C. IR (KBr): 3200, 1664, 1593 cm-1. 1H-NMR (10% CD3OD in CDCl3) δ: 1.70 (3H, s), 1.80 
(3H, s), 2.18 (3H, s), 2.64—4.54 (4H, m), 5.72 (1H, br d, J=7.5 Hz), 5.80 (1H, br d, J=7.5 Hz), 
6.57—7.28 (4H, m). MS m/z: 268 (M+). Anal. Calcd for C17H20N2O: C, 76.08; H, 7.51; N, 10.44. Found: 
C, 75.90; H, 7.59; N, 10.22. 
(E)-4-[4,5-Dimethoxy-2-(2-nitroethyl)phenyl]-2-methyl-3-buten-2-ol (11a) from (E,E)-4-[4,5- 
Dimethoxy-2-(2-nitrovinyl)phenyl]-2-methyl-3-buten-2-ol (13a) — NaBH4 (1.045g, 27.5 mmol) was 
added to a solution of 13a (2.009g, 6.86 mmol) in MeOH (120 mL) and the mixture was stirred at rt for 
30 min. Brine was added and the mixture was adjusted to pH 8 by adding 6% HCl. The whole was 
extracted with CH2Cl2–MeOH (95:5, v/v). The organic layer was washed with brine, dried over Na2SO4, 
and evaporated under reduced pressure to leave an oil, which was column-chromatographed on SiO2 
with Et2O–hexane (3:1, v/v) to give 11a (1.245 g, 62%). 11a: mp 99—100°C (colorless prisms, 
recrystallized from CH2Cl2–hexane). IR (KBr): 3460, 1602, 1538, 1503, 1343, 1261 cm-1. 1H-NMR 
(CDCl3) δ: 1.42 (6H, s), 1.83 (1H, br s, disappeared on addition of D2O), 3.27 (2H, t, J=7.2 Hz), 3.78 
(3H, s), 3.81 (3H, s), 4.43 (2H, t, J=7.2 Hz), 6.03 (1H, d, J=15.6 Hz), 6.52 (1H, s), 6.64 (1H, d, J=15.6 
Hz), 6.82 (1H, s). MS m/z: 295 (M+). Anal. Calcd for C15H21NO5·1/10H2O: C, 60.63; H, 7.19; N, 4.71. 
Found: C, 60.61; H, 7.27; N, 4.79. 
6,7-Dimethoxy-1-(2-methyl-1-propen-1-yl)-1,2,3,4-tetrahydroisoquinoline (12a) from 11a — A 
solution of 11a (50.9 mg, 0.17 mmol) in MeOH (6 mL) was added to a mixture of Zn powder in 6% HCl 
(2 mL), and the mixture was refluxed for 3 h with stirring. Unreacted Zn was filtered off and the filtrate 
was evaporated under reduced pressure. The residue was made basic by adding 8% NaOH and the whole 
was extracted with CH2Cl2–MeOH (95:5, v/v). The organic layer was washed with brine, dried over 
Na2SO4, and evaporated under reduced pressure to leave an oil, which was column-chromatographed on 
SiO2 with CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) to give 12a (28.7 mg, 67%). 12a: mp 57—58°C 
(colorless needles, recrystallized from petroleum ether). IR (KBr): 3400, 2910, 2760, 1605, 1509, 1259 
cm-1. 1H-NMR (CDCl3) δ: 1.80 (3H, d, J=1.2 Hz), 1.84 (3H, d, J=1.2 Hz), 2.04 (1H, br s, disappeared on 
addition of D2O), 2.44—3.40 (4H, m), 3.80 (3H, s), 3.84 (3H, s), 4.65 (1H, d, J=9.3 Hz), 5.28 (1H, br d, 
 J=9.3 Hz), 6.51 (1H, s), 6.57 (1H, s). MS m/z: 247 (M+). Anal. Calcd for C15H21NO2: C, 72.84; H, 8.56; 
N, 5.66. Found: C, 72.62; H, 8.66; N, 5.59. 
7-Benzyloxy-6-methoxy-1-(2-methyl-1-propen-1-yl)-1,2,3,4-tetrahydroisoquinoline (12b) from 11b 
— A solution of 11b (36.2 mg, 0.09 mmol) in MeOH (6 mL) was added to a mixture of Zn powder 
(332.1 mg, 5.08 mmol) in 6% HCl (2 mL) and the mixture was refluxed for 4 h with stirring. Unreacted 
Zn was filtered off and the filtrate was evaporated under reduced pressure. The residue was made basic 
by adding 20% NaOH and the whole was extracted with CH2Cl2–MeOH (95:5, v/v). The organic layer 
was washed with brine, dried over Na2SO4, and evaporated under reduced pressure to leave an oil, which 
was subjected to p-TLC on SiO2 with CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) as a developing 
solvent. Extraction of the band having an Rf value of 0.49—0.72 with CHCl3–MeOH–28% aq. NH3 
(46:5:0.5, v/v) gave 12b (24.2 mg, 77%). 12b: mp 114—116°C (colorless prisms, recrystallized from 
MeOH–H2O). IR (KBr): 3230, 2900, 1604, 1502, 1359, 1258, 1245, 1215 cm-1. 1H-NMR (CDCl3) δ: 
1.71 (6H, d, J=2 Hz), 1.89 (1H, br s, disappeared on addition of D2O), 2.46—2.89 (2H, m), 2.89—3.33 
(2H, m), 3.77 (3H, s), 4.46 (1H, d, J=9 Hz), 4.97 (2H, s), 5.07 (1H, br d, J=9 Hz), 6.36 (1H, s), 6.44 (1H, 
s), 7.02—7.45 (5H, m). MS m/z: 323 (M+). Anal. Calcd for C21H25NO2: C, 77.98; H, 7.79; N, 4.33. 
Found: C, 77.69; H, 7.83; N, 4.20. 
7-Benzyloxy-6-methoxy-2-methoxycarbonyl-1-(2-methyl-1-propen-1-yl)-1,2,3,4-tetrahydroisoquino
line (16) from 12b — A solution of ClCO2Me (45.4 mg, 0.48 mmol) in CH2Cl2 (1 mL) and Et3N (0.2 
mL) were added to a solution of 12b (82.4 mg, 0.26 mmol) in CH2Cl2 (4 mL) and the mixture was stirred 
at rt for 3 h. Saturated aqueous NaHCO3 was added and the whole was extracted with CH2Cl2–MeOH 
(95:5, v/v). The organic layer was washed with brine, dried over Na2SO4, and evaporated under reduced 
pressure to leave an oil, which was subjected to p-TLC on SiO2 with CH2Cl2–MeOH (99:1, v/v) as a 
developing solvent. Extraction of the band having an Rf value of 0.34—0.68 with CH2Cl2–MeOH (95:5, 
v/v) gave 16 (96.6 mg, 99%). 16: Colorless oil. IR (film): 1697, 1608 cm-1. 1H-NMR (CDCl3) δ: 1.67 
(3H, d, J=1.2 Hz), 1.83 (3H, d, J=1.2 Hz), 2.21—4.37 (4H, m), 3.61 (3H, s), 3.73 (3H, s), 4.91 (2H, s), 
5.08 (1H, br d, J=9.5 Hz), 5.49 (1H, d, J=9.5 Hz), 6.31 (1H, s), 6.39 (1H, s), 7.01—7.42 (5H, m). 
High-resolution MS m/z: Calcd for C23H27NO4: 381.1938. Found: 381.1956. 
7-Benzyloxy- (17) and 7-Hydroxy-6-Methoxy-2-methyl-1-(2-methyl-1-propen-1-yl)-1,2,3,4- 
tetrahydroisoquinoline (18) from 16 — LiAlH4 (109.2 mg, 0.29 mmol) was added to a solution of 16 
(96.6 mg, 0.25 mmol) in anhydrous THF (6 mL) and the mixture was refluxed for 24 h. After the 
addition of MeOH and saturated aqueous Rochelle salt under ice cooling, the whole was extracted with 
CH2Cl2–MeOH (95:5, v/v). The organic layer was washed with brine, dried over Na2SO4, and evaporated 
under reduced pressure to leave an oil, which was subjected to p-TLC on SiO2 with CHCl3–MeOH–28% 
aq. NH3 (46:5:0.5, v/v) as a developing solvent. Extraction of the band having an Rf value of 0.37—0.69 
 with CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) gave 17 (73.8 mg, 86%). 17: Colorless oil. IR (film): 
2930, 2780, 1610, 1507, 1252 cm-1. 1H-NMR (CDCl3) δ: 1.67 (3H, d, J=1.2 Hz), 1.85 (3H, d, J=1.5 Hz), 
2.15—3.28 (4H, m), 2.28 (3H, s), 3.72 (1H, d, J=9.5 Hz), 3.77 (3H, s), 4.93 (1H, d, J=9.5 Hz), 4.98 (2H, 
s), 6.35 (1H, s), 6.46 (1H, s), 7.02—7.38 (5H, m). High-resolution MS m/z: Calcd for C22H27NO2: 
337.2040. Found: 337.2038. Extraction of the band having an Rf value of 0.20—0.29 with 
CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) gave 18 (6.7 mg, 11%). 18: mp 159—160°C (colorless 
prisms, recrystallized from MeOH–H2O). IR (KBr): 2900, 1589, 1501, 1268 cm-1. 1H-NMR (CDCl3) δ: 
1.77 (6H, d, J=1.2 Hz), 2.17—3.17 (4H, m), 2.32 (3H, s), 3.74 (3H, s), 3.83 (1H, d, J=9.6 Hz), 4.77 (1H, 
br s, disappeared on addition of D2O), 5.05 (1H, br d, J=9.6 Hz), 6.42 (2H, s). MS m/z: 247 (M+). 
High-resolution MS m/z: Calcd for C15H21NO2: 247.1573. Found: 247.1569. 
(±)-Lophocerine (2) from 17 — A solution of 17 (30.9 mg, 0.09 mmol) in MeOH (7 mL) was 
hydrogenated in the presence of 10% Pd/C (33.7 mg) at rt and 1 atm for 7 h. Catalyst was filtered off and 
the filtrate was evaporated under reduced pressure to leave an oil, which was purified by p-TLC with 
CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) as a developing solvent. Extraction of the band having an Rf 
value of 0.37—0.50 with CHCl3–MeOH–28% aq. NH3 (46:5:0.5, v/v) gave 2 (8.8 mg, 39%). 2: 
Colorless oil. IR (film): 2940, 1592, 1505, 1461, 1360, 1266, 1210, 1130, 1102, 1021, 869, 775 cm-1. 
1H-NMR (CDCl3) δ: 0.90 (3H, d, J=6 Hz), 0.95 (3H, d, J=6 Hz), 1.22—2.02 (3H, m), 2.17—3.57 (5H, 
m), 2.40 (3H, s), 3.80 (3H, s), 4.33 (1H, br s, disappeared on addition of D2O), 6.43 (1H, s), 6.50 (1H, s). 
MS m/z: 249 (M+). 2·picrate: mp 194—196°C (lit.,5 mp 191.5—193°C, yellow prisms, recrystallized 
from benzene). IR (KBr): 3370, 2950, 1609, 1507, 1309, 1269 cm-1.  
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